淘屏美股招股说明书(2023-09-29版)

424B31form424b3.htm FiledPursuanttoRule424(b)(3)RegistrationNo.333-274153 ProspectusSupplementNo.2toProspectusdatedAugust30,2023 TAOPINGINC. Upto20,043,394OrdinaryShares ThisprospectussupplementamendsandsupplementstheprospectusdatedAugust30,2023,assupplementedoramendedfromtimetotime(the“Prospectus”),whichformsapartofourRegistrationStatementonFormF-1(RegistrationStatementNo.333-274153).ThisprospectussupplementisbeingfiledtoupdateandsupplementtheinformationincludedorincorporatedbyreferenceintheProspectuswiththeinformationcontainedinourReportonForm6-K,whichwasfurnishedtotheSecuritiesandExchangeCommissiononSeptember29,2023(the“Form6-K”).Accordingly,wehaveattachedtheForm6-Ktothisprospectussupplement. ThisprospectussupplementupdatesandsupplementstheinformationintheProspectusandisnotcompletewithout,andmaynotbedeliveredorutilizedexceptincombinationwith,theProspectus,includinganyamendmentsorsupplementsthereto.ThisprospectussupplementshouldbereadinconjunctionwiththeProspectusandifthereisanyinconsistencybetweentheinformationintheProspectusandthisprospectussupplement,youshouldrelyontheinformationinthisprospectussupplement. OurOrdinarySharesaretradedunderthesymbol“TAOP”ontheNasdaqCapitalMarket.OnSeptember28,2023,theclosingpriceofourOrdinarySharesontheNasdaqCapitalMarketwas$2.32. Wearea“foreignprivateissuer”underapplicablefederalsecuritieslawsand,assuch,wehaveelectedtocomplywithcertainreducedpubliccompanyreportingrequirementsfortheProspectusandfuturefilings. INVESTINGINOURSECURITIESINVOLVESAHIGHDEGREEOFRISK.YOUSHOULDCAREFULLYREADANDCONSIDERTHE“RISKFACTORS”BEGINNINGONPAGE8OFTHEPROSPECTUS. NeithertheSecuritiesandExchangeCommissionnoranystatesecuritiescommissionhasapprovedordisapprovedofthesesecuritiesordeterminedifthisprospectusistruthfulorcomplete.Anyrepresentationtothecontraryisacriminaloffense. ThedateofthisProspectusSupplementNo.2isSeptember29,2023. UNITEDSTATES SECURITIESANDEXCHANGECOMMISSION WASHINGTON,D.C.20549 FORM6-K REPORTOFFOREIGNPRIVATEISSUERPURSUANTTORULE13a-16OR15d-16OFTHESECURITIESEXCHANGEACTOF1934 Forthemonthof,September2023 CommissionFileNumber001-35722 TAOPINGINC. (Translationofregistrant’snameintoEnglish) 21stFloor,EverbrightBankBuildingZhuzilin,FutianDistrict Shenzhen,Guangdong518040People’sRepublicofChina (Addressofprincipalexecutiveoffices) IndicatebycheckmarkwhethertheregistrantfilesorwillfileannualreportsundercoverofForm20-ForForm40-F:Form20-F☒Form40-F☐ INCORPORATIONBYREFERENCE ThisForm6-KisherebyincorporatedbyreferenceintotheregistrationstatementsofTaopingInc.(the“Company”)onFormS-8(RegistrationNumbers333-256600and333-211363)andFormF-3(RegistrationNumbers333-262181and333-229323)totheextentnotsupersededbydocumentsorreportssubsequentlyfiledorfurnishedbytheCompanyundertheSecuritiesActof1933,asamended,ortheSecuritiesExchangeActof1934,asamended. OnSeptember27,2023,TaopingInc.(the“Company”)enteredintoaSecuritiesPurchaseAgreement(the“PurchaseAgreement”)withStreetervilleCapital,LLC,aUtahlimitedliabilitycompany(the“Investor”),pursuanttowhichtheCompanyissuedanunsecuredconvertiblepromissorynotewitha12-monthmaturity(the“Note”)toInvestor.TheNotehastheoriginalprincipalamountof$609,000.00includingtheoriginalissuediscountof$44,000andInvestor’slegalandothertransactioncostsof$15,000.TheCompanyanticipatesusingtheproceedsforgeneralworkingcapitalpurposes. InterestaccruesontheoutstandingbalanceoftheNoteat8%perannum.UpontheoccurrenceofaTriggerEvent(asdefinedintheNote),InvestormayincreasetheoutstandingbalancepayableundertheNoteby 15%or5%,dependingonthenatureofsuchevent.IftheCompanyfailstocuretheTriggerEventwithintherequiredfivetradingdays,theTrigerEventwillautomaticallybecomeaneventofdefaultandinterestwillaccrueatthelesserof22%perannumorthemaximumratepermittedbyapplicablelaw. PursuanttothetermsofthePurchaseAgreementandtheNote,theCompanymustobtainInvestor’sconsentforcertainfundamentaltransactionssuchasconsolidation,merger,dispositionofsubstantialassets,changeofcontrol,reorganizationorrecapitalization.AnyoccurrenceofsuchfundamentaltransactionwithoutInvestor’spriorwrittenconsentwillbedeemedaTriggerEvent. Investormay,atanytimeaftersixmonthsfromtheissuedate(“StartDate”),convertalloranypartoftheoutstandingbalanceoftheNote,ataconversionpriceof$8.00pershare.Inaddition,beginningontheStartDate,InvestormayredeemalloranyportionoftheNote,subjecttoamaximumamountof$150,000permonth,intoordinarysharesoftheCompanyatapriceequalto80%multipliedbythelowestdailyVWAPduringthetentradingdaysimmediatelyprecedingtheapplicableredemption,subjecttocertainadjustmentsandlimitations.Investoralsohastheright,onanytradingdayandthefollowingtradingday,thatanyintradaytradepriceoftheordinarysharesis10%greaterthanthepreviousMeasurementPeriod’sClosingTradePrice(asdefinedintheNote),toredeemalloranyportionoftheoutstandingbalanceoftheNoteintoordinaryshares.TheCompanyisresponsibleforcertainlatefeesequalto2%oftheConversionShareValue(asdefinedintheNote)withafloorof$500perdayifitfailstodelivertheordinarysharesuponconversionorredemptionpursuanttothetermsoftheNote.The